scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Earl S Ford | |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
metabolic syndrome | Q657193 | ||
P304 | page(s) | 1769-1778 | |
P577 | publication date | 2005-07-01 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence | |
P478 | volume | 28 |
Q58896395 | 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity |
Q36369792 | A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea. |
Q34635460 | A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria. |
Q42139168 | A critical analysis of the 2014 CUA guidelines for erectile dysfunction: Is there more that can be done? |
Q39127912 | A possible role of serum uric acid as a marker of metabolic syndrome |
Q88111296 | A posteriori dietary patterns and metabolic syndrome in adults: a systematic review and meta-analysis of observational studies |
Q40180740 | A specific prediction equation is necessary to estimate peak oxygen uptake in obese patients with metabolic syndrome |
Q37866294 | A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. |
Q37228958 | A traditional rice and beans pattern is associated with metabolic syndrome in Puerto Rican older adults |
Q58696694 | A variant in KCNQ1 gene predicts metabolic syndrome among northern urban Han Chinese women |
Q37003623 | AGE restriction in diabetes mellitus: a paradigm shift |
Q37411713 | AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease |
Q38663579 | APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome |
Q39163211 | ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria |
Q58736552 | Accuracy of insulin resistance indices for metabolic syndrome: a cross-sectional study in adults |
Q87962402 | Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study |
Q64965269 | Adherence to DASH-Style Dietary Pattern Impacts on Adiponectin and Clustered Metabolic Risk in Older Women. |
Q45757882 | Adherence to the DASH diet and prevalence of the metabolic syndrome among Iranian women |
Q33957120 | Aesthetic cardiology: adipose-derived stem cells for myocardial repair |
Q34227276 | Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. |
Q34237488 | Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk |
Q92718812 | Age- and sex- specific all-cause mortality risk greatest in metabolic syndrome combinations with elevated blood pressure from 7 U.S. cohorts |
Q33454936 | Aging, female sex, migration, elevated HDL-C, and inflammation are associated with prevalence of metabolic syndrome among African bank employees |
Q64989483 | Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population. |
Q80605785 | All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese |
Q40067661 | All-cause and cardiovascular mortality risk estimation using different definitions of metabolic syndrome in Lithuanian urban population |
Q87400011 | Altered neurovascular control of the resting circulation in human metabolic syndrome |
Q42918336 | American College Of Endocrinology Pre-Diabetes Consensus Conference: part one. |
Q102388899 | An epigenome-wide association study of metabolic syndrome and its components |
Q36348575 | An exploratory analysis of dynamic change of metabolic syndrome in relation to the risk of developing cardiovascular disease in a chinese cohort |
Q51328269 | An oral mixed fat load is followed by a modest anti-inflammatory adipocytokine response in overweight patients with metabolic syndrome. |
Q45287463 | Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease. |
Q59756381 | Anthropometrics, Metabolic Syndrome, and Mortality Hazard |
Q38615098 | Antidiabetic and antioxidant activity of Rhizophora mucronata leaves (Indian sundarban mangrove): An in vitro and in vivo study |
Q35778761 | Are Microalbuminuria and Elevated 24 H Urinary Microalbumin Excretion within Normal Range Associated with Metabolic Syndrome in Chinese Adults? |
Q46900862 | Artemisia herba-alba Asso (Asteraceae) has equivalent effects to green and black tea decoctions on antioxidant processes and some metabolic parameters in rats |
Q58152511 | Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models |
Q37257671 | Assessment of adipokines relationships with cardiovascular risk markers in relation to body indices in normoglycemic males |
Q50451370 | Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations. |
Q92457525 | Assessment of the relationship between metabolic syndrome and obstructive sleep apnea in male drivers of Shahroud city in 2018: a cross sectional study |
Q50025603 | Association between Metabolic Syndrome and Job Rank. |
Q45341378 | Association between history of abortion and metabolic syndrome in middle-aged and elderly Chinese women |
Q36648347 | Association between metabolic syndrome and premicroalbuminuria among Iranian women with Polycystic Ovary Syndrome: a case control study. |
Q43479482 | Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort |
Q52720564 | Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. |
Q36749924 | Association of Helicobacter pylori infection with the metabolic syndrome among HIV-infected black Africans receiving highly active antiretroviral therapy |
Q89431545 | Association of High-Risk Drinking with Metabolic Syndrome and Its Components in Elderly Korean Men: The Korean National Health and Nutrition Examination Survey 2010-2012 |
Q64100155 | Association of Relative Handgrip Strength and Metabolic Syndrome in Korean Older Adults: Korea National Health and Nutrition Examination Survey VII-1 |
Q89477335 | Association of Sensory Liking for Fat with Dietary Intake and Metabolic Syndrome in Korean Adults |
Q43699713 | Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study |
Q49165667 | Association of circulating branched-chain amino acids with cardiometabolic traits differs between adults and the oldest-old |
Q55517937 | Association of dietary patterns with continuous metabolic syndrome in children and adolescents; a nationwide propensity score-matched analysis: the CASPIAN-V study. |
Q34552004 | Association of insulin resistance indexes to carotid intima-media thickness |
Q36768698 | Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey |
Q47095179 | Association of metabolic syndrome and its components with all-cause and cardiovascular mortality in the elderly: A meta-analysis of prospective cohort studies |
Q21134687 | Association of sedentary behaviour with metabolic syndrome: a meta-analysis |
Q60044528 | Association of serum glycine levels with metabolic syndrome in an elderly Chinese population |
Q33739964 | Association of the apolipoprotein b/apolipoprotein a-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of georgia. |
Q34578911 | Association of vitamin D receptor gene polymorphisms with metabolic syndrome: a case-control design of population-based cross-sectional study in North China |
Q43257874 | Associations between lactase persistence and the metabolic syndrome in a cross-sectional study in the Canary Islands |
Q39712646 | Associations between psychological characteristics and indicators of metabolic syndrome among Chinese adults |
Q41592634 | Associations between the number of natural teeth and metabolic syndrome in adults |
Q55317670 | Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis. |
Q37556670 | Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG. |
Q38943225 | Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults |
Q91588858 | Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease |
Q33450226 | BeWell24: development and process evaluation of a smartphone "app" to improve sleep, sedentary, and active behaviors in US Veterans with increased metabolic risk |
Q49796680 | Beneficial association between active travel and metabolic syndrome in Latin-America: A cross-sectional analysis from the Chilean National Health Survey 2009-2010. |
Q40000439 | Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes |
Q35898326 | Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies |
Q89762134 | Blood Metabolite Signature of Metabolic Syndrome Implicates Alterations in Amino Acid Metabolism: Findings from the Baltimore Longitudinal Study of Aging (BLSA) and the Tsuruoka Metabolomics Cohort Study (TMCS) |
Q28392249 | Blood lead is significantly associated with metabolic syndrome in Korean adults: an analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008 |
Q35915412 | Blood rheology and platelet function in untreated early-stage essential hypertensives complicated with metabolic syndrome |
Q42917459 | Body composition and metabolic syndrome in patients with primary gout in Vietnam |
Q41918426 | Body fat distribution and its association with cardiovascular risk factors in adolescent Iranian girls |
Q47148642 | Breaking down, starting up: can a vitamin C-enriched gelatin supplement before exercise increase collagen synthesis? |
Q34847373 | COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats. |
Q35159990 | Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes |
Q35838500 | Canonical transient receptor potential channels in diabetes |
Q33621367 | Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome |
Q35071304 | Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor |
Q36063671 | Cardiometabolic effects in caregivers of nursing home placement and death of their spouse with Alzheimer's disease |
Q81204229 | Cardiometabolic risk and risk management. Introduction |
Q36394345 | Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus |
Q37159095 | Cardiometabolic risk: a Framingham perspective |
Q33625733 | Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations |
Q92924107 | Cardiovascular Health of Retired Field-Based Athletes: A Systematic Review and Meta-analysis |
Q39046196 | Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis |
Q39106973 | Cardiovascular consequences of metabolic syndrome. |
Q37153031 | Cardiovascular disease and modifiable cardiometabolic risk factors |
Q46028082 | Cardiovascular disease and modifiable cardiometabolic risk factors. |
Q51877973 | Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. |
Q43207802 | Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome |
Q33585366 | Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study |
Q37000075 | Cardiovascular risk in the metabolic syndrome: fact or fiction? |
Q79366076 | Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the "SYMFONIE" study |
Q37056120 | Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors |
Q36662926 | Challenges associated with metabolic syndrome |
Q35890372 | Challenges in the treatment of cardiometabolic syndrome |
Q37756812 | Characteristics of obesity and its related disorders in China |
Q98771397 | Childhood Obesity, Endothelial Cell Activation, and Critical Illness |
Q33899176 | Childhood trauma and metabolic syndrome in men and women |
Q24633315 | Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults |
Q90252212 | Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide |
Q92025378 | Clustering Effects of Metabolic Factors and the Risk of Metabolic Syndrome |
Q36325436 | Clustering of four major lifestyle risk factors among Korean adults with metabolic syndrome |
Q36210920 | Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis. |
Q33884912 | Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can) |
Q36329927 | Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial |
Q39618900 | Combined effects of the C161T and Pro12Ala PPARγ2 gene variants with insulin resistance on metabolic syndrome: a case-control study of a central Tunisian population |
Q58602651 | Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang |
Q44074164 | Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects |
Q58116632 | Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China |
Q53248709 | Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. |
Q92816345 | Comparison of the Serum Metabolic Fingerprint of Different Exercise Modes in Men with and without Metabolic Syndrome |
Q45337960 | Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance |
Q36512836 | Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function |
Q50458520 | Comparison of two exploratory dietary patterns in association with the metabolic syndrome in a Northern German population. |
Q38663160 | Consequences of bariatric surgery on oesophageal function in health and disease |
Q33698422 | Construct validity of a continuous metabolic syndrome score in children |
Q36258717 | Contributions of maternal and paternal adiposity and smoking to adult offspring adiposity and cardiovascular risk: the Midspan Family Study |
Q37564272 | Correction of Hypothyroidism Leads to Change in Lean Body Mass without Altering Insulin Resistance |
Q47173609 | Correlates of weight loss in persons with metabolic syndrome |
Q36192932 | Correlation between waist and mid-thigh circumference and cardiovascular fitness in Korean college students: a case study |
Q35603166 | Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome |
Q48512079 | Culturally Sensitive Education Can Decrease Hispanic Workers' Risk of Metabolic Syndrome |
Q46946713 | Depression and the metabolic syndrome: gender-dependent associations |
Q90401904 | Detection of metabolic syndrome burden in healthy young adults may enable timely introduction of disease prevention |
Q89484397 | Determinants of metabolic syndrome in obese workers: gender differences in perceived job-related stress and in psychological characteristics identified using artificial neural networks |
Q37143288 | Development of a field test for evaluating aerobic fitness in middle-aged adults: validity of a 15-m incremental shuttle walk and run test |
Q35813042 | Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults |
Q30986260 | Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Nutrition Examination (NHANES) 2001-2010 data. |
Q40425106 | Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women |
Q44112614 | Dietary patterns and the prevalence of metabolic syndrome in Korean women |
Q39945510 | Dietary patterns are associated with metabolic syndrome in an urban Mexican population. |
Q40106665 | Dietary polyphenols and metabolic syndrome among Iranian adults. |
Q26863519 | Dietary sodium reduction does not affect circulating glucose concentrations in fasting children or adults: findings from a systematic review and meta-analysis |
Q47263775 | Dietary supplementation with Lactobacillus plantarum dy-1 fermented barley suppresses body weight gain in high-fat diet-induced obese rats |
Q57213696 | Differences in Metabolic Syndrome Prevalence by Employment Type and Sex |
Q35942130 | Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: a meta-analysis |
Q34544837 | Different physical activity subtypes and risk of metabolic syndrome in middle-aged and older Chinese people |
Q38913816 | Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol |
Q37345498 | Differential influence of diet and physical activity on components of metabolic syndrome in a multiethnic sample of children |
Q37035092 | Dipeptidyl peptidase-iV inhibitors: fixing type 2 diabetes? |
Q37285705 | Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles |
Q36004382 | Divergent role of nitric oxide in insulin-stimulated aortic vasorelaxation between low- and high-intrinsic aerobic capacity rats |
Q37119260 | Do statins reduce events in patients with metabolic syndrome? |
Q83141007 | Does Apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly? |
Q92025250 | Does Protein Intake Affect Metabolic Risk Factors among Older Adults in Korea? |
Q46404667 | Does diagnosis of metabolic syndrome predict the likelihood of peripheral arterial disease as defined by a low ankle-brachial index? |
Q51916852 | Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. |
Q80728205 | Does metabolic syndrome predict silent carotid stenosis in coronary patients? |
Q92434431 | Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis |
Q53221986 | Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? |
Q46868484 | Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study |
Q36099467 | Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies |
Q37012904 | Doxazosin in metabolically complicated hypertension. |
Q51368718 | Early mechanisms of glucose improvement following laparoscopic ileal interposition associated with a sleeve gastrectomy evaluated by the euglycemic hyperinsulinemic clamp in type 2 diabetic patients with BMI below 35. |
Q33982776 | Effect of a multifaceted, church-based wellness program on metabolic syndrome in 41 overweight or obese congregants. |
Q35968042 | Effect of ethanolic extract of Cryptolepis sanguinolenta stem on in vivo and in vitro glucose absorption and transport: Mechanism of its antidiabetic activity |
Q35205577 | Effect of renal shock wave lithotripsy on the development of metabolic syndrome in a juvenile swine model: a pilot study |
Q36416919 | Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial |
Q35844076 | Effectiveness of a low-intensity telephone counselling intervention on an untreated metabolic syndrome detected by national population screening in Korea: a non-randomised study using regression discontinuity design. |
Q35345795 | Effectiveness of empowerment-based self-management interventions on patients with chronic metabolic diseases: a systematic review and meta-analysis |
Q51733988 | Effectiveness of the I2AO2 interdisciplinary programme led by nurses on metabolic syndrome and cardiovascular risk: a randomized, controlled trial. |
Q37081323 | Effects of 12 weeks of combined exercise training on visfatin and metabolic syndrome factors in obese middle-aged women |
Q48044379 | Effects of 6-month aerobic interval training on skeletal muscle metabolism in middle-aged metabolic syndrome patients |
Q41782754 | Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes |
Q103826087 | Effects of Capsicum annuum supplementation on the components of metabolic syndrome: a systematic review and meta-analysis |
Q37728550 | Effects of Different Exercise Modes on the Urinary Metabolic Fingerprint of Men with and without Metabolic Syndrome. |
Q36205687 | Effects of Tai Chi and Walking Exercises on Weight Loss, Metabolic Syndrome Parameters, and Bone Mineral Density: A Cluster Randomized Controlled Trial |
Q48962033 | Effects of a Cardiovascular Risk Reduction Intervention With Psychobehavioral Strategies for Korean Adults With Type 2 Diabetes and Metabolic Syndrome |
Q34623147 | Effects of a community-based weight loss intervention on adipose tissue circulating factors |
Q38590016 | Effects of bariatric surgery on markers of subclinical atherosclerosis and endothelial function: a meta-analysis of literature studies. |
Q47393480 | Effects of depression, metabolic syndrome, and cardiorespiratory fitness on mortality: results from the Cooper Center Longitudinal Study |
Q59607692 | Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study |
Q51350715 | Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study. |
Q48239979 | Effects of metabolic syndrome on language functions in aging |
Q38613017 | Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach |
Q55006279 | Effects of smoking and aerobic exercise on male college students' metabolic syndrome risk factors. |
Q54115284 | Effects of treadmill exercise on PI3K/AKT/GSK-3β pathway and tau protein in high-fat diet-fed rats. |
Q87885977 | Efficacy of high-intensity, low-volume interval training compared to continuous aerobic training on insulin resistance, skeletal muscle structure and function in adults with metabolic syndrome: study protocol for a randomized controlled clinical tri |
Q37492990 | Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome |
Q28762629 | Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes |
Q27023901 | Endogenous sex hormones, metabolic syndrome, and diabetes in men and women |
Q33682776 | Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. |
Q53693603 | Epigenome-wide association study of metabolic syndrome in African-American adults. |
Q89257150 | ErbB4 deletion predisposes to development of metabolic syndrome in mice |
Q83179752 | Establishment of a cut-point value of serum TNF-alpha levels in the metabolic syndrome |
Q90169533 | Estimating expected life-years and risk factor associations with mortality in Finland: cohort study |
Q36991963 | Evidence for the benefit of exercise therapy in patients with type 2 diabetes |
Q36775741 | Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance |
Q33573616 | Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis |
Q92369782 | Exercise training prevents the perivascular adipose tissue-induced aortic dysfunction with metabolic syndrome |
Q36415833 | Exercise, fitness, and cardiovascular disease risk in type 2 diabetes and the metabolic syndrome |
Q45983621 | Factor analysis of metabolic syndrome components in severely obese girls and boys. |
Q40708420 | Factors associated with metabolic syndrome among Korean office workers |
Q37495697 | Familial young-onset diabetes, pre-diabetes and cardiovascular disease are associated with genetic variants of DACH1 in Chinese |
Q91810964 | Fat Mass Index Better Identifies Metabolic Syndrome: Insights from Patients in Early Outpatient Cardiac Rehabilitation |
Q64912806 | Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome. |
Q37612824 | Fenofibrate and metabolic syndrome |
Q34041888 | Fetal programming and metabolic syndrome |
Q36249930 | Fluvastatin: efficacy and safety in reducing cardiac events |
Q41986990 | Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease |
Q37328287 | Gender and Age Impacts on the Association Between Thyroid Function and Metabolic Syndrome in Chinese |
Q39818776 | Gender differences among middle-aged Koreans for health-related quality of life related to metabolic syndrome |
Q36560976 | Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome |
Q30202787 | Gender- and race-specific metabolic score and cardiovascular disease mortality in adults: A structural equation modeling approach--United States, 1988-2006 |
Q35919437 | Genetic and Environmental Regulation on Longitudinal Change of Metabolic Phenotypes in Danish and Chinese Adult Twins. |
Q36054834 | Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men |
Q34560555 | Genetic determinants of the metabolic syndrome |
Q55500589 | Genetic profiling of young and aged endothelial progenitor cells in hypoxia. |
Q38239995 | Genetics of metabolic syndrome |
Q36756626 | Global coronary heart disease risk assessment of individuals with the metabolic syndrome in the U.S. |
Q40947023 | Handgrip strength is associated with metabolic syndrome among middle-aged and elderly community-dwelling persons |
Q48343088 | Health-related quality of life in adults with metabolic syndrome: the Korea national health and nutrition examination survey, 2007-2008. |
Q34609585 | Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis |
Q33811776 | Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. |
Q34974919 | High anger expression exacerbates the relationship between age and metabolic syndrome |
Q51325833 | High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. |
Q92579578 | High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes |
Q34707208 | How I treat late effects in adults after allogeneic stem cell transplantation |
Q36383027 | How to best define the metabolic syndrome |
Q37189315 | Hypertension as part of the metabolic syndrome |
Q36369676 | Hypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician |
Q51148825 | Hyperuricaemia in congenital heart disease patients. |
Q37414516 | Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study. |
Q44615223 | IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients |
Q93252790 | Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers |
Q37206605 | Identification of Normal Blood Pressure in Different Age Group |
Q33600203 | Identification of cardiometabolic risk among collegiate football players |
Q45754647 | Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria |
Q33505849 | Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records |
Q33940875 | Impact of Fenofibrate on Type 2 Diabetes Patients with Features of the Metabolic Syndrome: Subgroup Analysis From FIELD. |
Q37590178 | Impact of OSA on biological markers in morbid obesity and metabolic syndrome |
Q36848440 | Impact of Weight Loss Surgery on Esophageal Physiology |
Q34224453 | Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project |
Q46426614 | Impact of chronic kidney disease on the severity of initially diagnosed coronary artery disease and the patient prognosis in the Japanese population |
Q37233172 | Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno-Sobetsu Study |
Q64990848 | Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes. |
Q34015104 | Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease |
Q46833700 | Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community |
Q30620489 | Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity. |
Q47297790 | Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation |
Q36980202 | Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study |
Q93116600 | Improved quantification of muscle insulin sensitivity using oral glucose tolerance test data: the MISI Calculator |
Q43281503 | Improving insulin resistance with traditional Chinese medicine in type 2 diabetic patients |
Q35540575 | Improving physical activity and metabolic syndrome indicators in women: a transtheoretical model-based intervention. |
Q39911700 | Incidence and risk factors for the metabolic syndrome in an urban South European population |
Q35855960 | Incidence of Metabolic Syndrome and Its Risk Factors among Type 2 Diabetes Clinic Attenders in Isfahan, Iran |
Q43160862 | Increase in the prevalence of metabolic syndrome among workers according to age. |
Q34614038 | Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study |
Q51371210 | Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers. |
Q47108643 | Increased susceptibility of post-weaning rats on high-fat diet to metabolic syndrome. |
Q36538377 | Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial |
Q37158376 | Incremental increases in economic burden parallels cardiometabolic risk factors in the US. |
Q36087134 | Independent Associations between Sedentary Time, Moderate-To-Vigorous Physical Activity, Cardiorespiratory Fitness and Cardio-Metabolic Health: A Cross-Sectional Study. |
Q46560187 | Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity |
Q36643542 | Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. |
Q92812693 | Influence of Cardiometabolic Risk Factors on Platelet Function |
Q36860517 | Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease |
Q53158766 | Insertion/deletion polymorphism of angiotensin-1 converting enzyme is associated with metabolic syndrome in Hungarian adults. |
Q37801630 | Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome |
Q92650104 | Insulin Resistance in Patients With Acromegaly |
Q46671155 | Insulin resistance and adverse lipid profile in obese pre-pubertal South Indian children |
Q36625077 | Intake and circulating concentrations of antioxidants in metabolic syndrome |
Q34627358 | Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults |
Q99235477 | Integrating anthropometric and cardiometabolic health methods in stress, early experiences, and development (SEED) science |
Q34878952 | Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. |
Q36995886 | Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome |
Q64227354 | Interventional Effects of Weight-Loss Policy in a Healthy City among Participants with Metabolic Syndrome |
Q51244167 | Intestinal resection-associated metabolic syndrome. |
Q35143798 | Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRM |
Q34523714 | Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study |
Q92137571 | Is preeclampsia itself a risk factor for the development of metabolic syndrome after delivery? |
Q35510256 | Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. |
Q44190493 | Joint association of physical activity/screen time and diet on CVD risk factors in 10-year-old children |
Q34954938 | Joint effect of insulin signaling genes on all-cause mortality |
Q37395484 | Kidney pathological changes in metabolic syndrome: a cross-sectional study |
Q26749229 | Knowledge of healthy lifestyle in Iran: a systematic review |
Q41440898 | LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes |
Q43278810 | Lack of supervision after residential cardiac rehabilitation increases cardiovascular risk factors |
Q39959595 | Life-Course Socioeconomic Status and Metabolic Syndrome Among Midlife Women |
Q35397554 | Lifestyle-related factors and their association with metabolic syndrome in Korean adults: a population-based study |
Q33901790 | Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women |
Q36078200 | Linkage of epidemiologic evidence with the clinical aspects of metabolic syndrome |
Q92253697 | Lipidomic profiling identifies signatures of metabolic risk |
Q43240008 | Long-term temporal trends in cardiovascular and metabolic risk factors |
Q36206183 | Loss of Estrogen Receptor α Signaling Leads to Insulin Resistance and Obesity in Young and Adult Female Mice |
Q36800726 | Low levels of physical activity are associated with increased metabolic syndrome risk factors in korean adults. |
Q24628547 | Low-income Supplemental Nutrition Assistance Program participation is related to adiposity and metabolic risk factors |
Q35173230 | Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA Normative Aging Study |
Q38692706 | Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome |
Q37476440 | MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet |
Q92889557 | Macronutrient intake and physical activity levels in individuals with and without metabolic syndrome: An observational study in an urban population |
Q37615756 | Major components of metabolic syndrome and adiponectin levels: a cross-sectional study. |
Q36646276 | Management of hypertension and dyslipidemia |
Q46714886 | Management of the metabolic syndrome in cardiovascular disease |
Q36796216 | Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift |
Q34073832 | Managing mixed dyslipidemia in special populations |
Q36054814 | Mechanisms of macrophage activation in obesity-induced insulin resistance |
Q36518668 | Medication Use and Metabolic Syndrome Among Overweight/Obese Patients With and Without Binge-Eating Disorder in a Primary Care Sample |
Q35559325 | Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial |
Q58553707 | Meta-Analysis of Adiponectin as a Biomarker for the Detection of Metabolic Syndrome |
Q34422527 | Meta-analysis on night shift work and risk of metabolic syndrome. |
Q40366239 | Metabolic Risk Score and Vascular Mortality Among Korean Adults. |
Q92084884 | Metabolic Syndrome Among Young Health Professionals in the Multicenter Latin America Metabolic Syndrome Study |
Q53509978 | Metabolic Syndrome Prevalence and Reduction in Inmates Prescribed Antipsychotic Medications. |
Q34681110 | Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. |
Q52358229 | Metabolic Syndrome among Adults of Surendranagar District of Saurashtra, Gujarat: A Cross-Sectional Study. |
Q36634531 | Metabolic Syndrome and Cardiovascular Risk Factors in a National Sample of Adolescent Population in the Middle East and North Africa: The CASPIAN III Study |
Q55025268 | Metabolic Syndrome in First Episode Schizophrenia, Based on the National Mental Health Registry of Schizophrenia (NMHR) in a General Hospital in Malaysia: A 10-Year Retrospective Cohort Study. |
Q38494560 | Metabolic Syndrome: Does it Differ Between Women and Men? |
Q36915212 | Metabolic syndrome according to different definitions in a rapidly developing country of the African region |
Q37022974 | Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study |
Q38137667 | Metabolic syndrome and associated chronic kidney diseases: nutritional interventions |
Q47393422 | Metabolic syndrome and cardiovascular risk assessment tools' estimations of 10-year cardiovascular risk: a population-based study. |
Q37400542 | Metabolic syndrome and central obesity in depression: A cross-sectional study |
Q34453266 | Metabolic syndrome and chronic kidney disease: Current status and future directions |
Q46553599 | Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease |
Q44871514 | Metabolic syndrome and incident coronary heart disease in Australian indigenous populations |
Q34790658 | Metabolic syndrome and incident diabetes: current state of the evidence |
Q36749240 | Metabolic syndrome and its association with morbidity and mortality |
Q36319729 | Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis |
Q44038990 | Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study |
Q42052182 | Metabolic syndrome and mortality |
Q34460710 | Metabolic syndrome and outcomes after renal intervention |
Q36552277 | Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions |
Q50551373 | Metabolic syndrome and psychiatrists' choice of follow-up interventions in patients treated with atypical antipsychotics in Denmark and Sweden. |
Q37064695 | Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study |
Q46132793 | Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT). |
Q57222080 | Metabolic syndrome and sex-specific socio-economic disparities in childhood and adulthood: the Korea National Health and Nutrition Examination Surveys |
Q45927610 | Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006-2007). |
Q37257046 | Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definition |
Q35122374 | Metabolic syndrome and the burden of cardiovascular disease in Caribbean Hispanic women living in northern Manhattan: a red flag for education |
Q34250713 | Metabolic syndrome as an indicator of high cardiovascular risk in patients with diabetes: Analyses based on Korea National Health and Nutrition Examination Survey (KNHANES) 2008 |
Q91668401 | Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression |
Q35075053 | Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes |
Q33709804 | Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes |
Q85631710 | Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study |
Q38853283 | Metabolic syndrome in children and adolescents: Old concepts in a young population |
Q44508389 | Metabolic syndrome in heart transplantation: impact on survival and renal function. |
Q34251860 | Metabolic syndrome in hypertensive patients: An unholy alliance |
Q38044776 | Metabolic syndrome in patients with hematological diseases. |
Q38943809 | Metabolic syndrome in schizophrenia patients associated with poor premorbid school performance in early adolescence |
Q34511240 | Metabolic syndrome in the elderly living in marginal peri-urban communities in Quito, Ecuador |
Q33421460 | Metabolic syndrome in the elderly: an overview of the evidence |
Q46696000 | Metabolic syndrome in three ethnic groups using current definitions |
Q45944720 | Metabolic syndrome increases mortality in heart failure. |
Q35190268 | Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation |
Q33795888 | Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: a cross-sectional study |
Q37374394 | Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease |
Q43612365 | Metabolic syndrome is strictly associated with parental obesity beginning from childhood |
Q36975722 | Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry |
Q27011246 | Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis |
Q43449404 | Metabolic syndrome showed significant relationship with carotid atherosclerosis |
Q36163696 | Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults |
Q33960247 | Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study |
Q37417693 | Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis |
Q34595173 | Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. |
Q34985147 | Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study |
Q36292440 | Metabolic syndrome, endothelial dysfunction, and erectile dysfunction: association and management |
Q33765906 | Metabolic syndrome: a challenging health issue in highly urbanized Union Territory of north India |
Q36929371 | Metabolic syndrome: an evolving threat in the genesis of coronary artery disease |
Q37982204 | Metabolic syndrome: definition and therapeutic implications |
Q35047747 | Metabolic syndrome: definitions and controversies. |
Q36477959 | Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women? |
Q37509271 | Metabolic syndrome: perception or reality? |
Q35304395 | Metabolic syndrome: prevalence among American Indian and Alaska native people living in the southwestern United States and in Alaska |
Q48701926 | Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non-endemic country |
Q40274682 | Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and Type 2 diabetes |
Q49804673 | Mindfulness Is Associated with the Metabolic Syndrome among Individuals with a Depressive Symptomatology |
Q33579861 | Modeling the shape and composition of the human body using dual energy X-ray absorptiometry images |
Q39881409 | Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy |
Q35023196 | Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity |
Q28389434 | Mortality benefit of participation in BOOCS program: a follow-up study for 15 years in a Japanese working population |
Q34183468 | Mortality trends in the general population: the importance of cardiorespiratory fitness |
Q92670706 | Motivational Counseling to Reduce Sedentary Behaviors and Depressive Symptoms and Improve Health-Related Quality of Life Among Women With Metabolic Syndrome |
Q39213508 | National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study |
Q27026371 | New insights into the pathogenesis of renal calculi |
Q46612188 | Nigella sativa Oil and Chromium Picolinate Ameliorate Fructose-Induced Hyperinsulinemia by Enhancing Insulin Signaling and Suppressing Insulin-Degrading Enzyme in Male Rats |
Q33641341 | Nitric Oxide and Related Aspects Underlying Angina |
Q33699001 | Nuclear receptors, mitochondria and lipid metabolism |
Q36313635 | Number of medications is associated with outcomes in the elderly patient with metabolic syndrome |
Q92874410 | Nutritional Challenges in Metabolic Syndrome |
Q37604957 | Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry |
Q57118463 | Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment |
Q36727088 | On the use of a continuous metabolic syndrome score in pediatric research |
Q47547298 | Optimal waist circumference cut-off points for predicting metabolic syndrome among low-income black South African adults. |
Q37083329 | Optimizing management of metabolic syndrome to reduce risk: focus on life-style. |
Q49468098 | Oral Microbiota: Microbial Biomarkers of Metabolic Syndrome Independent of Host Genetic Factors |
Q37869270 | Overweight, obesity, and metabolic syndrome in adults and children in South Korea: a review of the literature |
Q24541527 | PPAR delta: a dagger in the heart of the metabolic syndrome |
Q38674742 | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. |
Q51314047 | Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans. |
Q36900984 | Pathogenesis and treatment of HIV lipohypertrophy |
Q28085060 | Per-Arnt-Sim Kinase (PASK): An Emerging Regulator of Mammalian Glucose and Lipid Metabolism |
Q35177897 | Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome |
Q43102878 | Phosphate and CVD: it's all in what's on the table |
Q36595961 | Physical activity and non-movement behaviours: their independent and combined associations with metabolic syndrome |
Q33489061 | Physical activity and risk of metabolic syndrome in an urban Mexican cohort. |
Q36686061 | Physical activity or fitness and the metabolic syndrome |
Q87650953 | Plasma lipids, lipoprotein metabolism and HDL lipid transfers are equally altered in metabolic syndrome and in type 2 diabetes |
Q59329570 | Population attributable fractions for Type 2 diabetes: an examination of multiple risk factors including symptoms of depression and anxiety |
Q38900562 | Population health and Mediterranean diet in southern Mediterranean countries |
Q30372054 | Population-based metabolic syndrome risk score and its determinants: The Isfahan Healthy Heart Program. |
Q35894983 | Postprandial Responses to Lipid and Carbohydrate Ingestion in Repeated Subcutaneous Adipose Tissue Biopsies in Healthy Adults. |
Q36419891 | Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis |
Q44360702 | Pre-morbid intelligence, the metabolic syndrome and mortality: the Vietnam Experience Study |
Q34173271 | Preclinical left ventricular diastolic dysfunction in metabolic syndrome. |
Q36467532 | Prediabetes and cardiovascular risk in hypertensive patients |
Q47184291 | Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy |
Q43491642 | Predicting type 2 diabetes mellitus using haemoglobin A1c: a community-based historic cohort study |
Q51371683 | Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study. |
Q44825411 | Prediction of women's long-term cardiometabolic risks using glycemic indices during pregnancy |
Q35612772 | Predictive Power for Type 2 Diabetes Mellitus using Dynamic Change of Metabolic Syndrome, Dynamic Change of Fasting Plasma Glucose, Metabolic Syndrome and Fasting Plasma Glucose |
Q43001186 | Predictive power of the components of metabolic syndrome in its development: a 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS). |
Q35872201 | Predictors of metabolic syndrome in participants of a cardiac rehabilitation program |
Q47551124 | Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors' cohort: A comparison with controls from the French population |
Q34417436 | Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency |
Q40588968 | Prevalence and sociodemographic correlates of metabolic syndrome in school-aged children and their parents in nine Mesoamerican countries |
Q34354248 | Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. |
Q37373760 | Prevalence of Metabolic Syndrome among Korean Adolescents According to the National Cholesterol Education Program, Adult Treatment Panel III and International Diabetes Federation |
Q47102498 | Prevalence of Metabolic Syndrome and its Associated Factors among Multi-ethnic Adults in Rural Areas in Xinjiang, China |
Q36537512 | Prevalence of Metabolic Syndrome and its Related Risk Factors in the City of Oran, Algeria: the ISOR Study |
Q37316036 | Prevalence of Reduced Kidney Function by Estimated Glomerular Filtration Rate Using an Equation Based on Creatinine and Cystatin C in Metabolic Syndrome and Its Components in Korean Adults. |
Q33593669 | Prevalence of cardio-metabolic risk factors in a nationally representative sample of Iranian adolescents: The CASPIAN-III Study |
Q51408050 | Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. |
Q38916947 | Prevalence of metabolic abnormalities in the Tunisian adults: a population based study |
Q34779481 | Prevalence of metabolic syndrome among urban community residents in China |
Q36861098 | Prevalence of metabolic syndrome and diabetes mellitus in Sami and Norwegian populations. The SAMINOR-a cross-sectional study |
Q44676405 | Prevalence of metabolic syndrome and its associated factors in a rural area of Minas Gerais State (MG, Brazil) |
Q37011521 | Prevalence of metabolic syndrome and its risk factors in Canadian children and adolescents: Canadian Health Measures Survey Cycle 1 (2007-2009) and Cycle 2 (2009-2011) |
Q35118002 | Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study |
Q35607305 | Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classifications |
Q39709268 | Prevalence of metabolic syndrome in Iran: A 2011 update |
Q33959950 | Prevalence of metabolic syndrome in Murcia Region, a southern European Mediterranean area with low cardiovascular risk and high obesity |
Q36348798 | Prevalence of metabolic syndrome in adult population from zahedan, southeast iran. |
Q94500060 | Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study |
Q35686811 | Prevalence of metabolic syndrome in type 2 diabetes mellitus patients |
Q33645121 | Prevalence of neck pain in subjects with metabolic syndrome--a cross-sectional population-based study |
Q37646606 | Prevalence of the metabolic syndrome and determination of optimal cut-off values of waist circumference in university employees from Angola |
Q30396880 | Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study |
Q58173473 | Prevalence of the metabolic syndrome and its relationship with diabetes mellitus by aging |
Q37384100 | Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study |
Q33785378 | Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study |
Q34785993 | Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. |
Q37296432 | Prevalence of the metabolic syndrome in rheumatoid arthritis |
Q64248657 | Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action: A Systematic Review |
Q46960307 | Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: what makes the difference? |
Q58209743 | Progression to impaired glucose regulation, diabetes and metabolic syndrome in Chinese women with a past history of gestational diabetes |
Q64060851 | Propofol Alleviates Apoptosis Induced by Chronic High Glucose Exposure via Regulation of HIF-1 in H9c2 Cells |
Q37084274 | Psoriasis comorbidities |
Q36617196 | Psychosocial factors and obesity in 17 high-, middle- and low-income countries: the Prospective Urban Rural Epidemiologic study |
Q34358909 | Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trial. |
Q39363428 | Quantity and quality of nocturnal sleep affect morning glucose measurement in acutely burned children |
Q27310173 | Rationale, design and methods for the RIGHT Track Health Study: pathways from childhood self-regulation to cardiovascular risk in adolescence |
Q34474422 | Receiver-operating characteristics of adiposity for metabolic syndrome: the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study |
Q41109088 | Recurrent pre-eclampsia in women with metabolic syndrome and low plasma volume: a retrospective cohort study |
Q36082229 | Regardless of central obesity, metabolic syndrome is a significant predictor of type 2 diabetes in Japanese Americans |
Q35182629 | Regular physical activity moderates cardiometabolic risk in Alzheimer's caregivers |
Q34892058 | Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses |
Q51354639 | Relation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome. |
Q35684267 | Relationship between Younger Age, Autoimmunity, Cardiometabolic Risk, Oxidative Stress, HAART, and Ischemic Stroke in Africans with HIV/AIDS |
Q55206386 | Relationship between heavy drinking, binge drinking, and metabolic syndrome in obese and non-obese Korean male adults. |
Q43269149 | Relationship between metabolic syndrome and periodontal disease in Japanese adults |
Q80376618 | Relationship between the change in overweight status from childhood to adolescence and metabolic syndrome phenotypes: a 9-year retrospective study |
Q98289183 | Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes |
Q34945093 | Relationship of the metabolic syndrome to carotid ultrasound traits |
Q61799509 | Relationships between Vitamin D₃ and Metabolic Syndrome |
Q35054776 | Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults |
Q21284498 | Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome |
Q90732462 | Religiosity and health: A global comparative study |
Q34026497 | Renal dysfunction, metabolic syndrome and cardiovascular disease mortality |
Q34594892 | Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromsø Study |
Q39587082 | Risk-benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes. |
Q61798755 | Role of Phosphatidylinositol 3-Kinase (PI3K), Mitogen-Activated Protein Kinase (MAPK), and Protein Kinase C (PKC) in Calcium Signaling Pathways Linked to the α1-Adrenoceptor in Resistance Arteries |
Q41257631 | SIRT3 protects endothelial cells from high glucose-induced cytotoxicity |
Q41595199 | Sasang constitutional types for the risk prediction of metabolic syndrome: a 14-year longitudinal prospective cohort study |
Q38221454 | Saturation diving; physiology and pathophysiology |
Q36410425 | Screening and risk stratification of patients with the metabolic syndrome and diabetes |
Q46639849 | Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese |
Q37670108 | Serum Calcium and the Risk of Incident Metabolic Syndrome: A 4.3-Year Retrospective Longitudinal Study. |
Q90079568 | Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels |
Q43472253 | Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity |
Q51482993 | Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. |
Q42869397 | Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States |
Q54966873 | Sex differences in relationships between metabolic syndrome components and factors associated with health-related quality of life in middle-aged adults living in the community: a cross-sectional study in Taiwan. |
Q35866437 | Sex differences in the regulation of body weight |
Q51244988 | Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria. |
Q79759732 | Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects |
Q53128043 | Simultaneous extraction of carotid artery intima-media interfaces in ultrasound images: assessment of wall thickness temporal variation during the cardiac cycle. |
Q90446710 | Single point insulin sensitivity estimator as an index for insulin sensitivity for metabolic syndrome: A study in North Indian population |
Q51743713 | Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome. |
Q40136623 | Snus use during the life-course and risk of the metabolic syndrome and its components |
Q35823257 | Socioeconomic status, psychosocial resources and risk, and cardiometabolic risk in Mexican-American women |
Q36562255 | Statins and the primary prevention of cardiovascular events |
Q26782194 | Stem cells: An eventual treatment option for heart diseases |
Q36433642 | Subclinical Vascular Dysfunction Associated with Metabolic Syndrome in African Americans and Whites |
Q45858326 | Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring |
Q43167225 | Sweetened beverage consumption and increased risk of metabolic syndrome in Mexican adults. |
Q33556676 | Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects |
Q58299638 | Systemic hemodynamics in young adults with the metabolic syndrome: The Cardiovascular Risk in Young Finns Study |
Q36782603 | Systemic oxidative stress is associated with lower aerobic capacity and impaired skeletal muscle energy metabolism in patients with metabolic syndrome. |
Q92307659 | TG : HDL-C Ratio Is a Good Marker to Identify Children Affected by Obesity with Increased Cardiometabolic Risk and Insulin Resistance |
Q51591547 | Taq1B Polymorphism of Cholesteryl Ester Transfer Protein (CETP) and Its Effects on the Serum Lipid Levels in Metabolic Syndrome Patients. |
Q38236212 | Targeting cellular drivers and counter-regulators of hyperglycaemia- and transforming growth factor-β1-associated profibrotic responses in diabetic kidney disease. |
Q40635890 | Ten-year change in sedentary behaviour, moderate-to-vigorous physical activity, cardiorespiratory fitness and cardiometabolic risk: independent associations and mediation analysis. |
Q35569892 | Test-retest reliability of peripheral arterial tonometry in the metabolic syndrome. |
Q37088526 | Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. |
Q43252220 | The 6th Annual World Congress on the Insulin Resistance Syndrome. |
Q35770053 | The Association between Apolipoprotein A-II and Metabolic Syndrome in Korean Adults: A Comparison Study of Apolipoprotein A-I and Apolipoprotein B |
Q92094257 | The Association between Fish Consumption and Risk of Metabolic Syndrome in Adults: Tehran Lipid and Glucose Study |
Q41203976 | The Association between Food Group Consumption Patterns and Early Metabolic Syndrome Risk in Non-Diabetic Healthy People. |
Q28395924 | The Association between Shift Work and the Metabolic Syndrome in Female Workers |
Q36022142 | The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome |
Q93126337 | The Emerging Role of l-Glutamine in Cardiovascular Health and Disease |
Q57153351 | The Epigenetics of Metabolic Syndrome |
Q50092083 | The Falconoid Luteolin Mitigates the Myocardial Inflammatory Response Induced by High-Carbohydrate/High-Fat Diet in Wistar Rats |
Q97526196 | The Impact of Education and Age on Metabolic Disorders |
Q54959460 | The Influence of Metabolic Syndrome and Sex on the DNA Methylome in Schizophrenia. |
Q37738141 | The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples |
Q30398720 | The Optimal Ethnic-Specific Waist-Circumference Cut-Off Points of Metabolic Syndrome among Low-Income Rural Uyghur Adults in Far Western China and Implications in Preventive Public Health |
Q39937516 | The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus |
Q92406464 | The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome |
Q28385811 | The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function--An Occupational Cohort-Based Study |
Q92708565 | The Syntaxin-1A gene single nucleotide polymorphism rs4717806 associates with the risk of ischemic heart disease |
Q44522887 | The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women |
Q48267314 | The anti-obesity effect of fermented barley extracts with Lactobacillus plantarum dy-1 and Saccharomyces cerevisiae in diet-induced obese rats |
Q55175780 | The association between insulin resistance, metabolic syndrome, and ischemic heart disease among Rumoi residents. |
Q91609246 | The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis |
Q28392243 | The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001-2010 |
Q35884380 | The association between serum albumin levels and metabolic syndrome in a rural population of Korea. |
Q43237429 | The association of dysglycaemia and cardiovascular disease in patients with metabolic syndrome |
Q64245557 | The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project |
Q51246246 | The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study. |
Q40109287 | The clinical significance of metabolic syndrome in hypertension: metabolic syndrome increases cardiovascular risk : the pro position |
Q36842540 | The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study |
Q37612072 | The cost-effectiveness of Maze procedures using ablation techniques at the time of mitral valve surgery. |
Q43152281 | The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome. |
Q51127959 | The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States. |
Q90704458 | The effects of L-carnitine supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials |
Q92962444 | The effects of Pandanus amaryllifolius (Roxb.) leaf water extracts on fructose-induced metabolic syndrome rat model |
Q35393502 | The epidemiology of uric acid and fructose |
Q33862044 | The establishment of metabolic syndrome model by induction of fructose drinking water in male Wistar rats. |
Q36092206 | The framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome |
Q38316845 | The impact of ethnicity and cardiovascular risk on the pharmacologic management of osteoarthritis: a US perspective |
Q51886706 | The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. |
Q36783273 | The importance of local criteria in the diagnosis of metabolic syndrome in Saudi Arabia |
Q80499609 | The medical cost of cardiometabolic risk factor clusters in the United States |
Q35546438 | The metabolic syndrome and cognitive performance: the Northern Manhattan Study |
Q36416116 | The metabolic syndrome and its relationship to hypertensive target organ damage |
Q36441966 | The metabolic syndrome and the heart--a considered opinion |
Q38263577 | The metabolic syndrome and urolithiasis: a systematic review and meta-analysis |
Q46919853 | The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius |
Q37024404 | The metabolic syndrome in East Asians |
Q40087419 | The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly |
Q44597940 | The metabolic syndrome: a critical appraisal based on the CUORE epidemiologic study |
Q39919146 | The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation |
Q30379006 | The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus |
Q48811744 | The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study |
Q36577007 | The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania. |
Q92904221 | The prevalence of metabolic syndrome among Ghanaian migrants and their homeland counterparts: the Research on Obesity and type 2 Diabetes among African Migrants (RODAM) study |
Q51368411 | The ratio of adiponectin to HOMA as an index of metabolic syndrome in obese women. |
Q33655398 | The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease |
Q31156777 | The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up |
Q43190449 | The rise and fall of the metabolic syndrome |
Q35036116 | The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies |
Q37061247 | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. |
Q37370220 | The sasang constitution as an independent risk factor for metabolic syndrome: propensity matching analysis |
Q35110360 | Therapeutic target achievement in type 2 diabetic patients after hyperglycemia, hypertension, dyslipidemia management |
Q37279099 | Threshold for improvement in insulin sensitivity with adolescent weight loss |
Q36824626 | Time-of-day and nutrient composition of eating occasions: prospective association with the metabolic syndrome in the 1946 British birth cohort |
Q47124822 | Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans |
Q35942210 | Treating metabolic syndrome: lifestyle change or medication? |
Q36815978 | Treating the metabolic syndrome. |
Q33610853 | Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros? |
Q36107317 | Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial. |
Q38784565 | U.S. military service and the prevalence of metabolic syndrome: Findings from a cross-sectional analysis of the Cooper Center Longitudinal Study, 1979-2013. |
Q39205505 | Uncoupling protein 2 and metabolic diseases |
Q37412698 | Update on the metabolic syndrome: hypertension |
Q35520336 | Use of plasma triglyceride/high-density lipoprotein cholesterol ratio to identify increased cardio-metabolic risk in young, healthy South Asians |
Q37094765 | Use of vascular ultrasound in clinical trials to evaluate new cardiovascular therapies |
Q37363488 | Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. |
Q57398619 | Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study |
Q45816440 | Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study |
Q34073895 | Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults |
Q46044501 | Vascular biomarkers in the metabolic syndrome |
Q24614381 | Vegetarian dietary patterns are associated with a lower risk of metabolic syndrome: the adventist health study 2 |
Q36238309 | Visceral Fat Area and Serum Adiponectin Level Predict the Development of Metabolic Syndrome in a Community-Based Asymptomatic Population |
Q101471063 | Vitamin A and D Absorption in Adults with Metabolic Syndrome versus Healthy Controls - A Pilot Study Utilizing Targeted and Untargeted LC-MS Lipidomics |
Q35898186 | Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study |
Q34557315 | Waist Circumference, Body Mass Index, and Other Measures of Adiposity in Predicting Cardiovascular Disease Risk Factors among Peruvian Adults |
Q100415880 | Waist-to-height ratio is a better discriminator of cardiovascular disease than other anthropometric indicators in Kurdish adults |
Q42079153 | Waist-to-height ratio is better than body mass index and waist circumference as a screening criterion for metabolic syndrome in Han Chinese adults |
Q38539937 | Weight loss interventions and progression of diabetic kidney disease |
Q42280882 | Which Components of Metabolic Syndrome have a Greater Effect on Mortality, CVA and Myocardial Infarction, Hyperglycemia, High Blood Pressure or Both? |
Q80314156 | Which obesity index best explains prevalence differences in type 2 diabetes mellitus? |
Q38667355 | Work-related psychosocial factors and onset of metabolic syndrome among workers: a systematic review and meta-analysis protocol. |
Q81415779 | [Steatosis during chronic hepatitis C: the role of insulin resistance and viral factors] |
Search more.